Surgery after proper imaging (MRI or CT scan) is the main stay of treatment for salivary gland tumors. Although excision margins should be >= 5 mm for malignant tumors in cases of parotid gland carcinoma, the facial nerve should be preserved whenever it is not infiltrated. Adjuvant external radiation is indicated for malignant tumors with high-risk features such as close (or invaded) margins, perineural speed, lymphatic and/or vascular invasion, lymph-node involvement and high-grade histology. A Phase II trial testing adjuvant concomitant cisplatin plus radiation therapy versus adjuvant radiation therapy alone after surgery is currently under investigation for high-risk salivary gland cancer. For inoperable cancers, photons combined with...
Salivary gland carcinomas are rare tumours and therapy strategies are less standardized than in lung...
About 50% of all minor salivary gland tumours are malignant. The principle site for malignant tumour...
Surgical resection remains the first line treatment for salivary gland cancer (SGC). In the case of ...
Surgery after proper imaging (MRI or CT scan) is the main stay of treatment for salivary gland tumor...
Surgery after proper imaging (MRI or CT scan) is the main stay of treatment for salivary gland tumor...
Salivary glands carcinomas are very rare epithelial malignant tumors. In 2013 in Europe, 7800 new di...
International audiencePrimary tumours of the salivary glands account for about 5 to 10% of tumours o...
Salivary gland cancers are rare and represent approximately 5% of all head and neck cancers and only...
The majority of the salivary gland tumours are of epithelial origin. The parotid gland is the most c...
Salivary gland cancers (SGCs) are rare diseases and their treatment depends upon histology, stage an...
Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery ...
Copyright © 2014 Meghan P. Olsen et al. This is an open access article distributed under the Creativ...
Purpose: We analyzed the role of primary and postoperative low linear energy transfer radiotherapy i...
PURPOSE: We analyzed the role of primary and postoperative low linear energy transfer radiotherapy i...
Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors...
Salivary gland carcinomas are rare tumours and therapy strategies are less standardized than in lung...
About 50% of all minor salivary gland tumours are malignant. The principle site for malignant tumour...
Surgical resection remains the first line treatment for salivary gland cancer (SGC). In the case of ...
Surgery after proper imaging (MRI or CT scan) is the main stay of treatment for salivary gland tumor...
Surgery after proper imaging (MRI or CT scan) is the main stay of treatment for salivary gland tumor...
Salivary glands carcinomas are very rare epithelial malignant tumors. In 2013 in Europe, 7800 new di...
International audiencePrimary tumours of the salivary glands account for about 5 to 10% of tumours o...
Salivary gland cancers are rare and represent approximately 5% of all head and neck cancers and only...
The majority of the salivary gland tumours are of epithelial origin. The parotid gland is the most c...
Salivary gland cancers (SGCs) are rare diseases and their treatment depends upon histology, stage an...
Salivary gland malignant tumors (SGMT) are of key interest for head and neck surgeons since surgery ...
Copyright © 2014 Meghan P. Olsen et al. This is an open access article distributed under the Creativ...
Purpose: We analyzed the role of primary and postoperative low linear energy transfer radiotherapy i...
PURPOSE: We analyzed the role of primary and postoperative low linear energy transfer radiotherapy i...
Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors...
Salivary gland carcinomas are rare tumours and therapy strategies are less standardized than in lung...
About 50% of all minor salivary gland tumours are malignant. The principle site for malignant tumour...
Surgical resection remains the first line treatment for salivary gland cancer (SGC). In the case of ...